ARCHIVES

In Senate testimony, NCI director uses survival rate as measure of progress for goal to “eliminate suffering and death due to cancer.”

This article is from The Cancer Letter archive.

Vol. 31 No. 30 | July 29, 2005

Download PDF Visit The Full Archive

Related Articles

Sense Of Excitement, Challenges, Mark Healy’s Debut

April 26, 1991

Better Access Key To Higher Survival For African-Americans With Colon Cancer

August 30, 2002

Gleevec Better Than Interferon For Newly Diagnosed CML

May 31, 2002

In Brief: Most NCI Grants, Including Noncompeting And r01s, Will Take Cuts Of At Least 4 Percent; Paylines Set

January 22, 1982

DePinho’s Handling Of MD Anderson Tenure Dispute Triggers Formal Investigation by AAUP

July 18, 2014

Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study

March 30, 2007